At the time of writing, STRATA Skin Sciences Inc [SSKN] stock is trading at $2.59, up 52.35%. An important factor to consider is whether the stock is rising or falling in short-term value. The SSKN shares have gain 85.00% over the last week, with a monthly amount glided 48.00%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer started tracking the stock with Outperform rating on November 21, 2019, and set its price target to $7. On December 10, 2018, Northland Capital initiated with a Outperform rating and assigned a price target of $7 on the stock. Rodman & Renshaw reiterated its Buy rating and increased its price target to $12 on May 16, 2017.
For the past year, the stock price of STRATA Skin Sciences Inc fluctuated between $1.38 and $3.86. STRATA Skin Sciences Inc [NASDAQ: SSKN] shares were valued at $2.59 at the most recent close of the market.
Analyzing the SSKN fundamentals
According to STRATA Skin Sciences Inc [NASDAQ:SSKN], the company’s sales were 32.85M for trailing twelve months, which represents an -9.15% plunge. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.36%, and Net Profit Margin reading is -0.35%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -2.67 and Total Capital is -0.61. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.52.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.2000 points at the first support level, and at 1.8100 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.0100, and for the 2nd resistance point, it is at 3.4300.
Ratios To Look Out For
It is important to note that STRATA Skin Sciences Inc [NASDAQ:SSKN] has a current ratio of 0.98. On the other hand, the Quick Ratio is 0.75, and the Cash Ratio is 0.43. Considering the valuation of this stock, the price to sales ratio is 0.42, the price to book ratio is 35.08.
